Pfizer Inc. (NYSE: PFE) is one of the 13 Best Fortune 500 dividend shares to invest in.
The company raises its adjusted EPS orientation and increases its total savings goal in the middle of an increase in income in the second quarter of 2025.
The results of the second quarter of Pfizer Inc. (NYSE: PFE) were reported on August 5, 2025, where it highlighted an increase year after year in revenues of 10%, reaching $ 14.7 billion. The growth of income was contributed in part by a strong demand and continuous growth for the Vyndaqel drug family due to the increase in diagnosis and treatment rates.
After the strong quarter, the company announced to raise its orientation EPS dilute adjusted from 2025 throughout the year at $ 0.10 to a range of $ 2.90 to $ 3.10. In addition, the company increased its cost reduction objective with additional savings of $ 1.7 billion to 2027. This increase increased the total savings objective to $ 7.7 billion. The company anticipates approximately $ 4.5 billion of these savings by the end of 2025.
Pfizer Inc. (NYSE: PFE) Heads our list of 13 best Fortune 500 dividend shares to invest, offering an attractive dividends of 7.20%.
Pfizer Inc. (NYSE: PFE) is a global pharmaceutical and biotechnology corporation, based in New York. The company was formed in 1849 and focuses on developing and manufacturing a wide range of medications and vaccines for various therapeutic areas, including oncology, cardiology and immunology.
While we recognize PFE’s potential as an investment, we believe that certain AI actions offer greater upward potential and have less downward risk. If you are looking for an extremely undervalued action that also benefits significantly from the Trump era tariffs and the wave trend, see our free report on the The best short -term AI actions.
Read below: 11 better performance opi in the last 2 years and 12 Jim Cramer stock selections this week
Divulgation. None.
(Tagstotranslate) Pfizer Inc.
Source link